Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT02964858
Eligibility Criteria:
Inclusion Criteria:
* Histological Diagnosis of NHL- DLBCL.
* Eligible for RT after R-CHOP.
* ECOG 0-3.
* 18 - 65 years.
* Stage I-IV.
* Patients should receive at least 4 cycles of R-CHOP chemotherapy.
* Patients with all extranodal disease except the ones mentioned in the exclusion criteria.
* Able to understand and willing to provide informed consent for participation in the trial.
Exclusion Criteria:
* HIV positive status.
* Relapse or progression of disease during chemotherapy.
* Prior history of chemotherapy
* Prior history of radiotherapy.
* Systemic lymphomas with CNS involvement.
* Primary extranodal Testicular Lymphomas.
* Primary extranodal central nervous system (CNS) Lymphomas.
* Primary extranodal Stomach DLBCL
* Primary extranodal Intestinal DLBCL
* Patients \>3 extranodal sites
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02964858
Study Brief:
Protocol Section:
NCT02964858